MartÃnez-Iglesias, O.; Naidoo, V.; Corzo, L.; Pego, R.; Seoane, S.; RodrÃguez, S.; Alcaraz, M.; Muñiz, A.; Cacabelos, N.; Cacabelos, R.
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes 2023, 14, 365.
https://doi.org/10.3390/genes14020365
AMA Style
MartÃnez-Iglesias O, Naidoo V, Corzo L, Pego R, Seoane S, RodrÃguez S, Alcaraz M, Muñiz A, Cacabelos N, Cacabelos R.
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes. 2023; 14(2):365.
https://doi.org/10.3390/genes14020365
Chicago/Turabian Style
MartÃnez-Iglesias, Olaia, Vinogran Naidoo, Lola Corzo, RocÃo Pego, Silvia Seoane, Susana RodrÃguez, Margarita Alcaraz, Adriana Muñiz, Natalia Cacabelos, and Ramón Cacabelos.
2023. "DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders" Genes 14, no. 2: 365.
https://doi.org/10.3390/genes14020365
APA Style
MartÃnez-Iglesias, O., Naidoo, V., Corzo, L., Pego, R., Seoane, S., RodrÃguez, S., Alcaraz, M., Muñiz, A., Cacabelos, N., & Cacabelos, R.
(2023). DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes, 14(2), 365.
https://doi.org/10.3390/genes14020365